AIV Logo AIV Assistant

 Logo Novacyt S.A. - ALNOV.PA 0.53 EUR

EPS
-0.63
P/B
0.60
ROE
-42.04
Beta
-1.57

0.530 EUR

0.530 EUR

Daily: +0.00%
Key Metrics

EPS: -0.63

Book Value: 1.00

Price to Book: 0.60

Debt/Equity: 18.67

% Insiders: 0.222%

Growth

Revenue Growth: 2.09%

Estimates

Forward P/E: 2.30

Forward EPS: 0.26

 Logo About Novacyt S.A. - (ALNOV.PA)

Country: United Kingdom

Sector: Health Care

Website: http://www.novacyt.com

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The company was incorporated in 2006 and is based in Le Vésinet, France.

Exchange Ticker
FRA (Germany) NYZ.F
LSE (United Kingdom) NCYT.L
PAR (France) ALNOV.PA
STU (Germany) NYZ.SG
PNK (United States) NVYTF

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion